| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/C1DT10125K |
| P698 | PubMed publication ID | 21403944 |
| P50 | author | Anthony J. H. M. Meijer | Q56880774 |
| Roberto Motterlini | Q56766953 | ||
| P2093 | author name string | Harry Adams | |
| Brian E Mann | |||
| Philip Sawle | |||
| David Scapens | |||
| Sian H Crook | |||
| P2860 | cites work | The therapeutic potential of carbon monoxide | Q29036279 |
| Metal carbonyls as pharmaceuticals? [Ru(CO)3Cl(glycinate)], a CO-releasing molecule with an extensive aqueous solution chemistry | Q31107951 | ||
| Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants | Q32133832 | ||
| Diversity and design of metal-based carbon monoxide-releasing molecules (CO-RMs) in aqueous systems: revealing the essential trends | Q33491574 | ||
| Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide | Q34980959 | ||
| Bioactivity and pharmacological actions of carbon monoxide-releasing molecules | Q35552289 | ||
| CO and NO in medicine | Q37064360 | ||
| Bench-to-bedside review: Carbon monoxide--from mitochondrial poisoning to therapeutic use. | Q37582537 | ||
| Bioactive properties of iron-containing carbon monoxide-releasing molecules | Q40294275 | ||
| Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages | Q40425297 | ||
| Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule | Q42169432 | ||
| Sonogashira and "Click" reactions for the N-terminal and side-chain functionalization of peptides with [Mn(CO)3(tpm)]+-based CO releasing molecules (tpm = tris(pyrazolyl)methane). | Q43296937 | ||
| Photoinduced CO release, cellular uptake and cytotoxicity of a tris(pyrazolyl)methane (tpm) manganese tricarbonyl complex | Q46671575 | ||
| Physiological and biochemical effects on rats and mice exposed to small concentrations of carbon monoxide for long periods | Q52331765 | ||
| Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. | Q53674243 | ||
| Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. | Q53975686 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4230-4235 | |
| P577 | publication date | 2011-03-14 | |
| P1433 | published in | Dalton Transactions | Q282900 |
| P1476 | title | [Mn(CO)4{S2CNMe(CH2CO2H)}], a new water-soluble CO-releasing molecule | |
| P478 | volume | 40 |
| Q64100432 | 3-Hydroxyflavones and 3-Hydroxy-4-oxoquinolines as Carbon Monoxide-Releasing Molecules |
| Q39506360 | A re-investigation of [Fe(L-cysteinate)2(CO)2]2-: an example of non-heme CO coordination of possible relevance to CO binding to ion channel receptors. |
| Q39304586 | A therapeutically viable photo-activated manganese-based CO-releasing molecule (photo-CO-RM). |
| Q36925719 | Antimicrobial Activity of the Manganese Photoactivated Carbon Monoxide-Releasing Molecule [Mn(CO)3(tpa-κ(3)N)](+) Against a Pathogenic Escherichia coli that Causes Urinary Infections |
| Q39080342 | Biological signaling by carbon monoxide and carbon monoxide-releasing molecules |
| Q38077548 | CO and CO-releasing molecules in medicinal chemistry |
| Q94661033 | CO as a therapeutic agent: discovery and delivery forms |
| Q89974128 | CO-mediated cytoprotection is dependent on cell metabolism modulation |
| Q38521451 | CO-releasing Metal Carbonyl Compounds as Antimicrobial Agents in the Post-antibiotic Era. |
| Q45309108 | CO-releasing molecules: avoiding toxicity and exploiting the beneficial effects of CO for the treatment of cardiovascular disorders |
| Q48053769 | Carbon monoxide shifts energetic metabolism from glycolysis to oxidative phosphorylation in endothelial cells |
| Q61837632 | Carbon monoxide-induced metabolic switch in adipocytes improves insulin resistance in obese mice |
| Q37995139 | Carbon monoxide: an unusual drug |
| Q28069274 | Characteristics of exogenous carbon monoxide deliveries |
| Q91990738 | Design and Biological Evaluation of Manganese- and Ruthenium-Based Hybrid CO-RMs (HYCOs) |
| Q37986364 | Developing drug molecules for therapy with carbon monoxide. |
| Q99421483 | Development of Triggerable, Trackable, and Targetable Carbon Monoxide Releasing Molecules |
| Q42323317 | Differential Effects of CORM-2 and CORM-401 in Murine Intestinal Epithelial MODE-K Cells under Oxidative Stress |
| Q38061514 | Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs). |
| Q90434421 | Extracellular vs Intracellular Delivery of CO: Does It Matter for a Stable, Diffusible Gasotransmitter? |
| Q58550047 | HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide |
| Q38010172 | Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly? |
| Q48304120 | Mono- and bimetallic manganese-carbonyl complexes and clusters bearing imidazol(in)ium-2-dithiocarboxylate ligands. |
| Q51546118 | Photo-activated CO-releasing molecules (PhotoCORMs) of robust sawhorse scaffolds [μ(2)-OOCR(1), η(1)-NH2CHR(2)(C = O] OCH3, Ru(I)2CO4]. |
| Q31117994 | Syntheses, properties and bio-activities of water-soluble CO-releasing molecule based on manganese |
| Q59164052 | Synthesis and Characterization of Manganese(I) Carbonyl Complexes of the Type [(OC)4Mn{μ-P(R)Aryl}]2 |
| Q47722784 | The Broad-Spectrum Antimicrobial Potential of [Mn(CO)4(S2CNMe(CH2CO2H))], a Water-Soluble CO-Releasing Molecule (CORM-401): Intracellular Accumulation, Transcriptomic and Statistical Analyses, and Membrane Polarization |
| Q36584960 | Toward Carbon Monoxide-Based Therapeutics: Critical Drug Delivery and Developability Issues |
| Q90086477 | Tracking CO release in cells via the luminescence of donor molecules and/or their by-products |
Search more.